Atul Lodh
Overview
Explore the profile of Atul Lodh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
77
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chapman M, Lodh A, Tristeza J, Yang A
Case Reports Hepatol
. 2024 Aug;
2024:8238951.
PMID: 39184226
While rare, cases of community-acquired () enterocolitis have been reported and are associated with recent antibiotic use and immunocompromised hosts. Here we present a 29-year-old immunocompetent female with newly diagnosed...
2.
Lodh A, Lee G, Weber F
Am J Gastroenterol
. 2024 Jul;
120(2):277.
PMID: 39023070
No abstract available.
3.
Ruli Jr T, Pollack E, Lodh A, Evers 3rd C, Price C, Shoreibah M
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893164
Primary liver cancer is one of the leading causes of cancer mortality worldwide, with hepatocellular carcinoma (HCC) being the most prevalent type of liver cancer. The prognosis of patients with...
4.
Munagala R, Mishra P, Lodh A, Shukla D, Bhatt A, Taskar V, et al.
Lung India
. 2021 Jul;
38(4):374-376.
PMID: 34259179
A 53-year-old African American male smoker presented with epigastric pain, tarry stools, and laboratory results indicative of acute pancreatitis. Chest X-ray showed a right perihilar mass with pleural effusion. Computed...
5.
Sayyid R, Reed W, Benton J, Lodh A, Woodruff P, Lambert J, et al.
Urol Oncol
. 2021 Mar;
39(11):782.e7-782.e14.
PMID: 33766466
Introduction: Current guidelines support active surveillance (AS) for select patients with favorable intermediate risk (FIR) prostate cancer (CaP). A significant proportion of FIR CaP patients undergoing surgical treatment are found...
6.
Sayyid R, Klotz L, Benton J, Lodh A, Lambert J, Woodruff P, et al.
Urology
. 2021 Feb;
155:117-123.
PMID: 33577898
Objectives: To investigate sociodemographic factors influencing decision of initially active surveillance (AS) prostate cancer (CaP) patients to opt for definitive therapy, and, specifically, choice of radical prostatectomy (RP) versus radiation...
7.
Sayyid R, Wilson B, Benton J, Lodh A, Thomas E, Goldberg H, et al.
Can Urol Assoc J
. 2020 Dec;
15(7):E335-E339.
PMID: 33382372
Introduction: A proportion of prostate cancer (PCa) patients initially managed with active surveillance (AS) are upgraded to a higher Gleason score (GS) at the time of radical prostatectomy (RP). Our...
8.
Goldberg H, Noorani R, Benton J, Lodh A, Berlin A, Chandrasekar T, et al.
Cancer Causes Control
. 2020 Oct;
32(1):47-55.
PMID: 33064242
Purpose: To examine cancer prevalence in men with and without military service history, using national-level self-reported outcomes. Methods: A cross-sectional survey-based US study, including men aged 18 and above from...
9.
Benton J, Lodh A, Watson A, Tingen M, Terris M, Wallis C, et al.
Prev Med
. 2020 Apr;
135:106075.
PMID: 32247011
Although the relationship between cigarette smoking and increased risk of malignancy has been well established, smoking remains a major public health threat in the United States. Therefore, we examined the...
10.
Benton J, Lodh A, Wallis C, Klaassen Z
Urology
. 2019 Oct;
132:47-48.
PMID: 31581997
No abstract available.